The intraperitoneal route involves delivering medications, fluids, or nutritional solutions directly into the peritoneal cavity, which is the space enclosed by the peritoneum in the abdomen. While rarely used for routine drug administration in general ward nursing, this route is vital in specific medical scenarios such as peritoneal dialysis, targeted chemotherapy for abdominal cancers, and rapid fluid resuscitation in emergency veterinary or specialized human settings. Understanding this pathway requires a grasp of how rapidly large surface areas inside the abdomen can absorb pharmacologic agents into the systemic circulation.
The peritoneum is a large, semi-permeable serous membrane divided into parietal and visceral layers. The parietal peritoneum lines the abdominal wall, while the visceral peritoneum wraps around the internal organs. This membrane covers a massive surface area roughly equal to the total skin surface of the body, featuring a rich network of blood and lymphatic capillaries. This extensive vascular supply makes the peritoneal lining an effective membrane for fluid and solute exchange.
When drugs enter the peritoneal cavity, absorption occurs primarily through the submesothelial capillary blood vessels and the lymphatic system. Lipid-soluble drugs cross the peritoneal membrane quickly via diffusion. A unique characteristic of intraperitoneal drug delivery in oncology is the peritoneal-plasma barrier, which allows high local concentrations of chemotherapy to affect peritoneal tumors directly while limiting systemic toxicity.
Administering substances intraperitoneally demands strict aseptic technique to prevent severe abdominal infections. Nurses must gather appropriate sterile supplies, including the prescribed solution, an administration set, antiseptic skin cleansers, and specialized catheters if permanent access ports are absent. Before infusion, ensure the solution is warmed to body temperature to prevent patient cramping and hypothermia. Monitor the patient's vital signs and abdominal comfort continuously throughout the procedure.
The most feared complication of intraperitoneal therapy is peritonitis, an inflammation of the peritoneal lining usually caused by bacterial contamination. Signs include cloudy effluent, severe abdominal pain, and fever. Other risks involve catheter displacement, bowel perforation, and fluid overload or electrolyte imbalances. Nurses must inspect exit sites daily, monitor fluid balance accurately, and report unusual pain or drainage immediately.
| Advantages | Disadvantages |
|---|---|
| Provides high local drug concentration to peritoneal tumors | Carries a high risk of peritonitis if sterile technique fails |
| Offers a massive surface area for rapid fluid and drug absorption | Causes discomfort, pain, or cramping during fluid instillation |
| Bypasses first-pass hepatic metabolism for certain agents | Requires specialized technical skill and specialized equipment |
| Useful when standard intravenous access is impossible | Can lead to fluid overload or respiratory restriction from pressure |